U.S. Water Utilities Stock News

NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Amneal Pharmaceuticals (AMRX) Valuation After Opioid Settlement Finalization And S&P Index Additions

Amneal Pharmaceuticals (AMRX) just stepped into the spotlight as its stock reacts to two big developments: the nationwide opioids settlement becoming effective and the company’s fresh inclusion in several S&P indices. See our latest analysis for Amneal Pharmaceuticals. The latest developments sit on top of a clear upswing in the stock, with a 30 day share price return of 13.53% and a 90 day share price return of 23.76%. The 1 year total shareholder return of 80.83% and the very large 3 year...
NasdaqGS:TTWO
NasdaqGS:TTWOEntertainment

Take Two Interactive Software (TTWO) Posts US$92.9m Quarterly Loss Testing Bullish Margin Narrative

How Take-Two Interactive Software (TTWO) Landed This Quarter Take-Two Interactive Software (TTWO) has reported Q3 2026 revenue of US$1.7b with a basic EPS loss of US$0.50, alongside trailing twelve month revenue of US$6.6b and a basic EPS loss of US$21.81. The company has seen quarterly revenue move from US$1.36b in Q3 2025 to US$1.58b in Q4 2025, US$1.50b in Q1 2026, US$1.77b in Q2 2026 and now US$1.70b in Q3 2026. Over the same stretch, basic EPS ranged from a loss of US$0.71 to a loss of...
NYSE:BOH
NYSE:BOHBanks

How Planned CEO Succession and Solid 2025 Results At Bank of Hawai‘i (BOH) Has Changed Its Investment Story

Bank of Hawai‘i recently announced that longtime Chairman and CEO Peter S. Ho will retire on March 31, 2026, with President and Chief Banking Officer James C. Polk slated to succeed him and Raymond P. Vara Jr. becoming Non-Executive Chairman as part of a long-planned leadership transition. This shift comes on the heels of a strong 2025, in which the bank reported higher net interest income, increased net income, and continued share repurchases, highlighting a focus on both operational...
NYSE:WY
NYSE:WYSpecialized REITs

Should Weyerhaeuser’s (WY) Biocarbon Push and Buybacks Shape Investors’ View of Its 2030 Strategy?

In late January 2026, Weyerhaeuser reported fourth-quarter 2025 net income of US$74 million, slightly lower than the prior year, while also completing a US$61.17 million share repurchase program initiated in May 2025. Despite modest quarterly earnings, the company’s expanded Climate Solutions and biocarbon initiatives, alongside its multiyear growth strategy through 2030, have attracted renewed analyst optimism about its broader business trajectory. With Weyerhaeuser’s recent focus on...
NasdaqGM:CDNA
NasdaqGM:CDNABiotechs

Can CareDx (CDNA) Turn AlloHeme’s ACROBAT Data Into a Durable Precision-Transplant Moat?

CareDx, Inc. has announced that pivotal 24‑month clinical validation data from its ACROBAT study of AlloHeme, an AI-powered NGS blood test for post‑transplant relapse monitoring in AML and MDS patients, will be presented at the 2026 Tandem Meetings in Salt Lake City. This presentation, spanning 11 U.S. transplant centers and building on earlier interim data, marks an important milestone for establishing AlloHeme’s real‑world clinical utility in hematologic malignancy relapse...
NasdaqGS:SONO
NasdaqGS:SONOConsumer Durables

Sonos (SONO) Q1 EPS Breakthrough Challenges Longstanding Profitability Concerns

Sonos (SONO) opened its 2026 financial year with Q1 revenue of US$545.7 million and basic EPS of US$0.78, alongside net income of US$93.8 million. This set a clear marker after last year’s mixed quarters. The company’s quarterly revenue moved from US$550.9 million in Q1 2025 to US$545.7 million in Q1 2026, while basic EPS shifted from US$0.41 to US$0.78 over the same period. These figures highlight how near term profitability is intersecting with longer term expectations around growth and...
NYSE:NABL
NYSE:NABLSoftware

Can N-able’s (NABL) New Agentic AI Push It Into the Cyber Resilience Big Leagues?

N-able, Inc. recently announced enhanced AI capabilities across its cyber resilience platform, applying agentic AI to endpoint management, security operations, and data protection for small- and medium-sized businesses. By harnessing telemetry from more than 11 million managed endpoints and over 25,000 technology service providers, N-able is turning vast operational data into unified, AI-driven tools that aim to reduce complexity while strengthening cyber defenses. We’ll now examine how...
NasdaqGS:EBC
NasdaqGS:EBCBanks

Do Eastern Bankshares' (EBC) 2025 Results Recast Its Capital Return Strategy Or Reinforce The Status Quo?

Eastern Bankshares, Inc. recently reported full-year 2025 results showing net interest income of US$828.6 million and net income of US$88.2 million, alongside a regular quarterly dividend of US$0.13 per share payable on March 20, 2026 to shareholders of record on March 6, 2026. The company also completed a share repurchase of 3,100,000 shares for US$55.4 million and reported quarterly net charge-offs of US$9.8 million, or 0.18% of average total loans, highlighting its ongoing capital...
NasdaqGS:BELF.A
NasdaqGS:BELF.AElectronic

Evaluating Bel Fuse (BELF.A) After Strong Recent Share Price Momentum

Why Bel Fuse is on investors’ radar today Bel Fuse (BELF.A) has been drawing attention after a strong run in recent months, with the stock showing a one-month return of 24.5% and a three-month return of 37.7%. See our latest analysis for Bel Fuse. That recent momentum, with a 24.5% 30 day share price return and 37.7% 90 day share price return, sits alongside a very large 5 year total shareholder return. This suggests that investors have been steadily reassessing Bel Fuse’s growth prospects...
NYSE:SCHW
NYSE:SCHWCapital Markets

Is It Too Late To Consider Charles Schwab (SCHW) After A 99% Five-Year Return?

If you are wondering whether Charles Schwab still offers good value at its current share price, or if most of the upside has already been priced in, this article breaks down what the numbers are actually saying about the stock today. The share price recently closed at US$103.88, with returns of 0.4% over 7 days, 0.1% over 30 days, 2.3% year to date, 28.4% over 1 year, 34.6% over 3 years and 99.1% over 5 years. This naturally raises questions about where valuation stands now. Recent headlines...
NYSE:CNMD
NYSE:CNMDMedical Equipment

A Look At CONMED (CNMD) Valuation After Earnings And Growth In Key Surgical Segments

CONMED (CNMD) shares were in focus after the company reported fourth quarter and full year 2025 results, issued 2026 revenue guidance, and highlighted momentum in orthopedics and high growth surgical segments. See our latest analysis for CONMED. At a share price of US$39.93, CONMED has seen short term momentum pick up, with a 1 day share price return of 2.94% and 7 day share price return of 3.21%. However, the 1 year total shareholder return of 45.45% and 5 year total shareholder return of...
NasdaqGS:APP
NasdaqGS:APPSoftware

Why AppLovin (APP) Is Down 28.6% After AI Ad-Tech Jitters Challenge Its Mobile Ad Model

In recent weeks, AppLovin has been caught in a broader software sell-off as investors reassessed the impact of new AI tools, such as Google’s Genie 3 and Project Genie, and emerging AI ad-tech challengers on established mobile advertising and app-monetization platforms. At the same time, several Wall Street analysts have argued that fears about AI displacing AppLovin’s role in game discovery, user acquisition and monetization may be overstated, keeping the company at the center of the debate...
NYSE:AFG
NYSE:AFGInsurance

American Financial Group Margin Softness Challenges Bullish Profitability Narratives

American Financial Group (AFG) has wrapped up FY 2025 with fourth quarter revenue of US$2.2b and basic EPS of US$3.59, alongside net income of US$299m. Its trailing twelve month figures sit at US$8.2b of revenue and EPS of US$10.08 on net income of US$842m. Over recent periods, quarterly revenue has ranged from US$1.8b to US$2.3b, while basic EPS has moved between roughly US$1.84 and US$3.59. This gives investors a clear view of how earnings track alongside top line shifts. With a trailing...
NasdaqGS:DLO
NasdaqGS:DLODiversified Financial

Assessing DLocal (DLO) Valuation As Its Emerging Markets Payments Platform Extends Reach And Product Offering

DLocal (DLO) is back in focus after highlighting the reach of its emerging market payments platform across more than 40 countries, alongside new BNPL, tokenized payment and stablecoin offerings. Fresh partnerships with Western Union, Google, Capitec, Bolt, Fireblocks and Grey are widening its network and giving investors more detail on how DLocal is trying to deepen its role in cross border payment flows. See our latest analysis for DLocal. Despite the product rollouts and new partnerships,...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

A Look At Axcelis Technologies (ACLS) Valuation After Recent Mixed Share Price Performance

Why Axcelis Technologies is on investors’ radar today Axcelis Technologies (ACLS) has drawn fresh attention after a period of mixed share performance, with a 1 day decline, a weaker past week and month, but a slightly positive past 3 months. For investors, that kind of uneven return profile often raises questions about how the current share price lines up with Axcelis’s actual business results and long term prospects in semiconductor equipment. See our latest analysis for Axcelis...
NYSE:BHE
NYSE:BHEElectronic

Benchmark Electronics (BHE) Margin Compression Reinforces Bearish Narratives Despite Revenue Progress

Benchmark Electronics (NYSE:BHE) has wrapped up FY 2025 with fourth quarter revenue of US$704.3 million and basic EPS of US$0.17, alongside net income excluding extra items of US$6.0 million, putting the spotlight firmly on how efficiently that top line is translating into profit. The company has seen quarterly revenue move from US$656.9 million and EPS of US$0.51 in Q4 2024 to US$704.3 million and EPS of US$0.17 in Q4 2025, with trailing twelve month EPS at US$0.69, which sets up a close...